SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000072
Filing Date
2018-11-07
Accepted
2018-11-07 07:27:31
Documents
8
Period of Report
2018-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 23960
2 EXHIBIT 99.1 pirsq318prfinal.htm EX-99.1 19839
3 pirsq318prfinal001.jpg GRAPHIC 297806
4 pirsq318prfinal002.jpg GRAPHIC 306786
5 pirsq318prfinal003.jpg GRAPHIC 122586
6 pirsq318prfinal004.jpg GRAPHIC 181328
7 pirsq318prfinal005.jpg GRAPHIC 80032
8 pirsq318prfinal006.jpg GRAPHIC 78162
  Complete submission text file 0001583648-18-000072.txt   1514843
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 181164710
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9